Sat 19 Sep 2026 International edition
♥ Support Us
Clinical Trials & Research BioVie’s Stock Plummets 33% Following SUNRISE-PD Phase IIb Trial Data Release Utilizing Novel, Company-Created EPNIC-15 Endpoint
Bio-Research & Life Sciences Skyfall Over the Tri-State: How a New Jersey Rooftop Meteorite Unlocked Secrets of Ancient Asteroid Brines and the Origins of Life
Oncology & Cancer Research Unlocking the Genetic Blueprint: How Inherited DNA Steers Tumor Evolution and Cancer Risk
Precision Medicine Unlocking Nutritional Dark Matter: How Advanced Food Science is Decoding the Hidden Universe on Our Plates
Precision Medicine Breaking the Ice: Breakthrough CRISPR-Based RNA Technology Turns "Cold" Prostate Tumors Visible to Immunotherapy
Precision Medicine Breaking the Cold: Experimental CRISPR RNA-Targeting Technology Turns Prostate Tumors into Immune System Beacons
Laboratory Medicine Capturing the Genesis of Extreme States: Researchers Unveil Femtosecond-Scale Plasma Dynamics in Breakthrough Experiment
Molecular Biology & Genomics Unlocking the Hive Mind: How Neurobiologists Decoded the Neural Circuits Controlling Honeybee Labor Division
Pathology & Histology Revolutionizing Cancer Diagnostics: The Breakthrough of Shock-Scattering Micro-Histotripsy-Aided Fine Needle Aspiration
Healthcare News & Policy Executive Overview: Unlocking the Early Mechanisms of Alzheimer’s Risk
Hematology & Blood Research Unlocking the Blueprint of Cure: Why Certain Cancers Succumb to Chemotherapy While Others Resist
Clinical Trials & Research PepGen Advances PGN-EDODM1 to Maximum Planned Dose in Phase II FREEDOM2-DM1 Trial Following Favorable Safety Review

Section 1

Section 2

Section 3

Section 4

Archive

Tag: colon